Global Transdermal Drug Delivery Market 2024-2028

Global Transdermal Drug Delivery Market 2024-2028

The transdermal drug delivery market is forecasted to grow by USD 2.44 bn during 2023-2028, accelerating at a CAGR of 4.9% during the forecast period. The report on the transdermal drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, increased applications of transdermal patches, and biodegradable and biocompatible materials for transdermal drug delivery.

Technavio's transdermal drug delivery market is segmented as below:

By Application

• Analgesics
• Neurological disorders
• Hormone replacement therapy
• Cardiovascular disorders
• Others

By Type

• Transdermal patches
• Transdermal semisolids

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing interest in transdermal medicines as one of the prime reasons driving the transdermal drug delivery market growth during the next few years. Also, robust demand for non-invasive treatment and growing focus on collaborations for business expansion will lead to sizable demand in the market.

The report on the transdermal drug delivery market covers the following areas:

• Transdermal drug delivery market sizing
• Transdermal drug delivery market forecast
• Transdermal drug delivery market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transdermal drug delivery market vendors that include 3M Co., Boehringer Ingelheim International GmbH, Croda International Plc, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson, Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Radius Health Inc., Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc.. Also, the transdermal drug delivery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.